Robert Young Kim, Chief Officer of 4D Molecular Therapeutics FDMT, has filed 0 purchases and 4 sales on the open market. The latest trade was on 25/03/06.

RK

RK

Robert Young Kim

Chief Medical Officer

Company

4D Molecular Therapeutics FDMT

First filing

23/12/13

Trades

12 trades

Buys / sales

0 / 4

12-month net buying

No record

Last trade

25/03/06

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/02/05	24/02/07	24,552 sh4 trades	$30.05avg.	$737,787.6	−95.9%